Literature DB >> 21821127

Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system.

Philip A Klenotic1, Richard C Page, Saurav Misra, Roy L Silverstein.   

Abstract

The matrix glycoprotein thrombospondin-1 (TSP-1) is a prominent regulator of endothelial cells and angiogenesis. The anti-angiogenic and anti-tumorigenic properties of TSP-1 are in part mediated by the TSP-1 type 1 repeat domains 2 and 3, TSR(2,3). Here, we describe the expression and purification of human TSR(2,3) in milligram quantities from an Escherichia coli expression system. Microvascular endothelial cell migration assays and binding assays with a canonical TSP-1 ligand, histidine-rich glycoprotein (HRGP), indicate that recombinant TSR(2,3) exhibits anti-chemotactic and ligand binding properties similar to full length TSP-1. Furthermore, we determined the structure of E. coli expressed TSR(2,3) by X-ray crystallography at 2.4Å and found the structure to be identical to the existing TSR(2,3) crystal structure determined from a Drosophila expression system. The TSR(2,3) expression and purification protocol developed in this study allows for facile expression of TSR(2,3) for biochemical and biophysical studies, and will aid in the elucidation of the molecular mechanisms of TSP-1 anti-angiogenic and anti-tumorigenic activities.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821127      PMCID: PMC3195888          DOI: 10.1016/j.pep.2011.07.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  39 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  CD36-TSP-HRGP interactions in the regulation of angiogenesis.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36.

Authors:  S Frieda; A Pearce; J Wu; R L Silverstein
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

4.  Autorosette inhibition factor: isolation and properties of the human plasma protein.

Authors:  D B Rylatt; D Y Sia; J P Mundy; C R Parish
Journal:  Eur J Biochem       Date:  1981-10

5.  The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues.

Authors:  J Hofsteenge; M Blommers; D Hess; A Furmanek; O Miroshnichenko
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

6.  A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1.

Authors:  M L Lamm; S M Sintich; C Lee
Journal:  Endocrinology       Date:  1998-02       Impact factor: 4.736

7.  Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors.

Authors:  P Sheffield; S Garrard; Z Derewenda
Journal:  Protein Expr Purif       Date:  1999-02       Impact factor: 1.650

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  10 in total

1.  Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.

Authors:  Martín Alcorlo; Agustín Tortajada; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

2.  CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia.

Authors:  Hong Yue; Maria Febbraio; Philip A Klenotic; David J Kennedy; Yueheng Wu; Shaoxian Chen; Amira F Gohara; Oliver Li; Adam Belcher; Bin Kuang; Thomas M McIntyre; Roy L Silverstein; Wei Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

3.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

4.  Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36.

Authors:  Philip A Klenotic; Richard C Page; Wei Li; Joseph Amick; Saurav Misra; Roy L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

Review 5.  Phosphatidylserine receptors: enhancers of enveloped virus entry and infection.

Authors:  Sven Moller-Tank; Wendy Maury
Journal:  Virology       Date:  2014-09-29       Impact factor: 3.616

6.  Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer.

Authors:  Yaxiong Cai; Shuange Yao; Jiangchuan Zhong; Jinxia Zhang; Haowu Jiang; Yanrui Deng; Ning Deng
Journal:  Oncotarget       Date:  2017-03-21

7.  Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury.

Authors:  Y Zhao; Z Xiong; E J Lechner; P A Klenotic; B J Hamburg; M Hulver; A Khare; T Oriss; N Mangalmurti; Y Chan; Y Zhang; M A Ross; D B Stolz; M R Rosengart; J Pilewski; P Ray; A Ray; R L Silverstein; J S Lee
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

8.  Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer.

Authors:  Yaxiong Cai; Jinxia Zhang; Xuejun Lao; Haowu Jiang; Yunfei Yu; Yanrui Deng; Jiangchuan Zhong; Yiye Liang; Likuan Xiong; Ning Deng
Journal:  Cancer Sci       Date:  2016-07-26       Impact factor: 6.716

9.  C-mannosylation supports folding and enhances stability of thrombospondin repeats.

Authors:  Aleksandra Shcherbakova; Matthias Preller; Manuel H Taft; Jordi Pujols; Salvador Ventura; Birgit Tiemann; Falk Fr Buettner; Hans Bakker
Journal:  Elife       Date:  2019-12-23       Impact factor: 8.140

10.  Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.

Authors:  Praveen M Varghese; Shuvechha Mukherjee; Futwan A Al-Mohanna; Souad M Saleh; Fahad N Almajhdi; Nazar Beirag; Saad H Alkahtani; Reena Rajkumari; Beatrice Nal Rogier; Robert B Sim; Susan Idicula-Thomas; Taruna Madan; Valarmathy Murugaiah; Uday Kishore
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.